Living Medicines: Engineering the Microbiome

Syngulon announces the issuance by the USPTO of a second patent covering the use of bacteriocin/immunity for the controlled growth of microorganisms

Renaissance BioScience Corp. partners with Mitacs in a million-dollar project to test precision yeast-based RNAi technologies for environmentally friendly agricultural biopesticides and medical biotherapeutics

Organism engineering

Home » Emerging technologies » Organism engineering » Page 3

Biosyntia

Biosyntia raises €4 million in Series A financing to advance its microbe engineering technology and bio-based product pipeline

Floyd Romesberg

Scripps Research chemist Floyd Romesberg receives prestigious Royal Society of Chemistry Award

DNA

Custom-built DNA could be used as a sensor probe

Renaissance BioScience

Renaissance BioScience partners with Mitacs for $1.44-million project

Synpromics awarded Innovate UK grant to evaluate its inducible promoter platform in collaboration with Lonza Pharma & Biotech

Transcriptic

DARPA Awards Ginkgo Bioworks and Transcriptic $9.5M to Bring AI into the Lab

News Digest #207 – Living Medicines, Living Paints, and Living Foundries are all on the rise

Living Medicines: Using Gut Microbes to Treat Disease

News Digest #201 – #MemoriesInDNA, SynBioBeta Early Bird Ends Wed, Synthetic Viruses and more.

Amyris Announces Over $25 Million in Grants